Correlation Between Aerovate Therapeutics and Boralex

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Boralex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Boralex into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Boralex, you can compare the effects of market volatilities on Aerovate Therapeutics and Boralex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Boralex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Boralex.

Diversification Opportunities for Aerovate Therapeutics and Boralex

-0.69

Correlation Coefficient

Aerovate Therapeutics  Boralex

Excellent diversification

The 3 months correlation between Aerovate and Boralex is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Boralex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boralex and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Boralex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boralex has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Boralex go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Boralex

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 2.1 times more return on investment than Boralex. However, Aerovate Therapeutics is 2.1 times more volatile than Boralex. It trades about 0.0 of its potential returns per unit of risk. Boralex is currently generating about -0.02 per unit of risk. If you would invest  2,494  in Aerovate Therapeutics on October 7, 2024 and sell it today you would lose (2,226) from holding Aerovate Therapeutics or give up 89.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	77.82%
Values	Daily Returns

Aerovate Therapeutics  vs.  Boralex

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Boralex

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Boralex has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Aerovate Therapeutics and Boralex

The main advantage of trading using opposite Aerovate Therapeutics and Boralex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Boralex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boralex will offset losses from the drop in Boralex's long position.

The idea behind Aerovate Therapeutics and Boralex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.